EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Galunisertib During Normothermic Machine Perfusion Attenuates Profibrotic Signaling in Discarded Human Donor Kidneys

C C Pamplona iD, C Ballester Bergada iD, C L Jaynes iD, T L Hamelink iD, V A Lantinga iD, B Ogurlu iD, P Ottens, P Olinga iD, K van Hateren, D Touw iD, J L Hillebrands iD, H G D Leuvenink iD und 2 weitere

Artificial Organs · 18.11.2026

DOI: 10.1111/aor.70281 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Artificial Organs, online erschienen am 18.11.2026. Verfasst von C C Pamplona und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery-Organ Donation and Transplantation, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: stimag, 34Lives.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Early‐onset fibrosis limits kidney transplant success, causing early allograft failure in up to 50% of deceased donor kidneys within 10 years or excluding many from transplantation. Normothermic machine perfusion (NMP) offers a platform for targeted drug delivery to isolated organs, minimizing systemic effects. This study evaluated whether galunisertib modulates fibrosis‐associated molecular signaling when administered to discarded human kidneys during ex vivo NMP, while assessing treatment safety and pharmacokinetics.

Methods

Twelve discarded human kidneys underwent 4 h of oxygenated hypothermic perfusion followed by 6 h of NMP with galunisertib or vehicle ( n = 6). Precision‐cut kidney slices (PCKS) were then cultured for 48 h with either continued or discontinued galunisertib exposure. Endpoints included fibrosis‐related mRNA expression and pharmacokinetics.

Results

Galunisertib was administered during NMP and steadily excreted in urine without adverse effects on organ function. Continued exposure in PCKS significantly attenuated fibrosis‐related mRNA expression, including SERPINE1 (24 h: p = 0.0057; 48 h: p = 0.0046). Discontinuation increased ACTA2 expression ( p = 0.0156), while continued treatment prevented this phenomenon ( p = 0.0014).

Conclusion

NMP enabled targeted delivery of galunisertib to discarded human kidneys without detectable adverse effects on ex vivo renal function. Prolonged galunisertib exposure was associated with modest attenuation of fibrosis‐associated molecular markers during subsequent tissue culture. These findings provide proof‐of‐concept for pharmacological modulation of profibrotic signaling during ex vivo kidney perfusion.

Schlagwörter

Stichwörter der Autor:innen

ex vivo perfusionfibrogenesisfibrosisgalunisertibprecision‐cut tissue slicesrenal transplantation

Autor:innen und Institutionen

  • Department of Surgery-Organ Donation and Transplantation, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Department of Clinical Medicine-Renal Medicine, Aarhus University, Aarhus, Denmark.
  • 34 Lives, West-Lafayette, Indiana, USA.
  • Department of Pharmaceutical Technology and Biopharmacy, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, the Netherlands.
  • Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Department of Pathology and Medical Biology, Section of Pathology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

ORCID-Profile: C C Pamplona, C Ballester Bergada, C L Jaynes, T L Hamelink, V A Lantinga, B Ogurlu, P Olinga, D Touw, J L Hillebrands, H G D Leuvenink, C Moers, L L van Leeuwen

Förderung

  • stimag
  • 34Lives

Zitieren

APA

Pamplona, C. C., Ballester Bergada, C., Jaynes, C. L., Hamelink, T. L., Lantinga, V. A., Ogurlu, B., Ottens, P., Olinga, P., van Hateren, K., Touw, D., Hillebrands, J. L., Leuvenink, H. G. D., Moers, C., & van Leeuwen, L. L. (2026). Galunisertib During Normothermic Machine Perfusion Attenuates Profibrotic Signaling in Discarded Human Donor Kidneys. Artificial Organs. https://doi.org/10.1111/aor.70281

Vancouver

Pamplona CC, Ballester Bergada C, Jaynes CL, Hamelink TL, Lantinga VA, Ogurlu B, et al. Galunisertib During Normothermic Machine Perfusion Attenuates Profibrotic Signaling in Discarded Human Donor Kidneys. Artificial Organs. 2026. doi:10.1111/aor.70281

BibTeX
@article{Pamplona2026,
  author = {Pamplona, C C and Ballester Bergada, C and Jaynes, C L and Hamelink, T L and Lantinga, V A and Ogurlu, B and Ottens, P and Olinga, P and van Hateren, K and Touw, D and Hillebrands, J L and Leuvenink, H G D and Moers, C and van Leeuwen, L L},
  title = {Galunisertib During Normothermic Machine Perfusion Attenuates Profibrotic Signaling in Discarded Human Donor Kidneys},
  journal = {Artificial Organs},
  year = {2026},
  doi = {10.1111/aor.70281}
}
Kostenlos starten →